One in five Medicare beneficiaries with diabetes has undiagnosed peripheral artery disease (PAD) — and 85% of amputations start as an untreated diabetic foot ulcer (DFU). This is one of the most preventable causes of limb loss in Medicare care, and standard practice usually doesn't catch it until infection or ulceration has already set in.
Synchronize Health's Zero DFU Program screens for the vascular problem before the wound forms. Every practice receives a MESI mTABLET for rapid ABI/TBI PAD screening, and at-risk patients receive a connected foot-temperature monitor from Bluedrop Medical — when the Bluedrop device identifies a sustained deviation of 2.2°C or more within its cleared function, its alert reaches the Synchronize Health care team, which routes confirmed risk straight to a wound care or vascular specialist. Podiatrists, who see this population daily, are a core referral partner in the model, not an afterthought.
By supporting consistent data collection and care team communication, the program provides the treating physician and wound care specialist with longitudinal patient data to inform their ongoing clinical assessment between encounters. It is also built to move the CMS quality measures that matter most — acute hospital utilization, readmissions, and CAHPS patient experience.
This isn't a wound-care add-on. It's a front door — patients identified through PAD and DFU screening frequently carry overlapping cardiovascular, renal, and metabolic risk, and transition naturally into the broader Clinical Status Monitoring platform.
More patients keep their independent mobility. The rest is cost avoidance the health system keeps.